Department of Pharmacy, Kindai University Nara Hospital, Ikoma, Japan.
J Chemother. 2021 Dec;33(8):539-546. doi: 10.1080/1120009X.2021.1915074. Epub 2021 Jun 1.
This study aimed to investigate the relationship between renal dysfunction and electrolyte abnormalities, which are adverse events of foscarnet used for cytomegalovirus infection. Of the Ninety hematopoietic stem cell transplantation patients, 32 who met the selection criteria were enrolled in this retrospective study. The study patients were divided into two groups according to whether they developed renal dysfunction. The incidences of hypocalcemia, hypokalemia, and hypomagnesemia with an increase of grade 2 or higher in the renal dysfunction group were 45.5%, 18.2%, and 27.3%, respectively. Additionally, in the renal dysfunction group, a significant correlation was observed between creatinine and calcium (r = -0.458, = 0.0244) and between creatinine and potassium (r = -0.520, = 0.0092). This study shows that renal dysfunction and electrolyte abnormalities may be closely related in HSCT patients receiving foscarnet; thus, it is a report that may contribute to the safety of continuous foscarnet treatment.
本研究旨在探讨肾功能障碍与电解质异常之间的关系,这些是膦甲酸钠用于巨细胞病毒感染的不良事件。在 90 例造血干细胞移植患者中,符合选择标准的 32 例患者被纳入本回顾性研究。根据是否发生肾功能障碍,将研究患者分为两组。肾功能障碍组低钙血症、低钾血症和低镁血症的发生率分别为 45.5%、18.2%和 27.3%,且肾功能障碍组中,肌酐与钙(r = -0.458,P = 0.0244)和肌酐与钾(r = -0.520,P = 0.0092)之间存在显著相关性。本研究表明,接受膦甲酸钠治疗的 HSCT 患者中,肾功能障碍与电解质异常可能密切相关;因此,这是一份有助于膦甲酸钠连续治疗安全性的报告。